BDBM72287 6,7-dimethyl-4-(3-nitrophenyl)-3,4-dihydro-1H-quinolin-2-one::6,7-dimethyl-4-(3-nitrophenyl)-3,4-dihydro-2(1H)-quinolinone::6,7-dimethyl-4-(3-nitrophenyl)-3,4-dihydrocarbostyril::MLS000665452::SMR000270689::cid_2916903

SMILES Cc1cc2NC(=O)CC(c3cccc(c3)[N+]([O-])=O)c2cc1C

InChI Key InChIKey=QAUKYGUCLDVAMS-UHFFFAOYSA-N

Data  1 EC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 72287   

TargetSodium channel protein type 10 subunit alpha(Human)
Glaxosmithkline Intellectual Property Development

US Patent
LigandChemical structure of BindingDB Monomer ID 72287BDBM72287(34-Fluoro-27-(trifluoromethyl)-11,12,21,22,23,24-h...)
Affinity DataIC50: 25.1nMAssay Description:Keywords: Heat Shock Factor-1 (HSF-1), Stress Response, MG132, NIH3T3, Luminescence Assay Overview: Modified NIH3T3, transformed to express firefly...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/16/2026
Entry Details US Patent